Proteomic analysis of isolated membrane fractions from superinvasive cancer cells

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 1, 2007, Pages 93-101

  Dowling, Paul ^a   Meleady, Paula ^a   Dowd, Andrew ^a   Henry, Michael ^a   Glynn, Sharon ^a   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Cofilin; DIGE; Galectin 3; Membrane protein; Superinvasive

Indexed keywords

BETA ACTIN; CHAPERONE; COFILIN; GALECTIN 3; GUANINE NUCLEOTIDE BINDING PROTEIN; HEAT SHOCK PROTEIN 70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; PACLITAXEL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL MEMBRANE; FLUORESCENCE; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TEMPERATURE DEPENDENCE; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PACLITAXEL; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33846012211     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.09.014     Document Type: Article

References (58)

1. Friedl P., and Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev., Cancer 3 (2003) 362-374
2. Glynn S.A., Gammell P., Heenan M., O'Connor R., Liang Y., Keenan J., and Clynes M. A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin. Br. J. Cancer 91 (2004) 1800-1807
3. Glynn S.A., Adams A., Gibson B., Cronin D., Harmey J.H., and Clynes M. Low adhesiveness coupled with high superinvasiveness in vitro predicts the in vivo metastatic potential of a mouse mammary adenocarcinoma cell line. Anticancer Res. 26 (2006) 1001-1010
4. Alban A., David S.O., Bjorkesten L., Andersson C., Sloge E., Lewis S., and Currie I. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3 (2003) 36-44
5. Cailleau R., Olive M., and Cruciger Q.V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14 (1978) 911-915
6. Ellison G., Klinowska T., Westwood R.F., Docter E., French T., and Fox J.C. Further evidence to support the melanocytic origin of MDA-MB-435. Mol. Pathol. 55 (2002) 294-299
7. Rae J.M., Ramus S.J., Waltham M., Armes J.E., Campbell I.G., Clarke R., Barndt R.J., Johnson M.D., and Thompson E.W. Common origins of MDA-MB-435 cells from various sources with those shown to have melanoma properties. Clin. Exp. Metastasis 21 (2004) 543-552
8. Albini A., Melchiori A., Santi L., Liotta L.A., Brown P.D., and Stetler-Stevenson W.G. Tumor cell invasion inhibited by TIMP-2. J. Natl. Cancer Inst. 83 (1991) 775-779
9. Bordier C. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256 (1981) 1604-1607
10. Santoni V., Kieffer S., Desclaux D., Masson F., and Rabilloud T. Membrane proteomics: use of additive main effects with multiplicative interaction model to classify plasma membrane proteins according to their solubility and electrophoretic properties. Electrophoresis 21 (2000) 3329-3344
11. Liang Y., Meleady P., Cleary I., McDonnell S., Connolly L., and Clynes M. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness. Eur. J. Cancer 37 (2001) 1041-1052
12. Nangia-Makker P., Honjo Y., Sarvis R., Akahani S., Hogan V., Pienta K.J., and Raz A. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am. J. Pathol. 156 (2000) 899-909
13. Warfield P. Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. Biochem. Biophys. Res. Commun. 246 (1998) 788-791
14. Inohara H., Akahani S., Koths K., and Raz A. Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 56 (1996) 4530-4534
15. Cherayil B.J., Weiner S.J., and Pillai S. The Mac-2 antigen is a galactosespecific lectin that binds IgE. J. Exp. Med. 170 (1989) 1959-1972
16. Inohara H., and Raz A. Identification of human melanoma cellular and secreted ligands for galectin-3. Biochem. Biophys. Res. Commun. 201 (1994) 1366-1375
17. Rosenberg I., Cherayil B.J., Isselbacher K.J., and Pillai S. Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin. J. Biol. Chem. 266 (1991) 18731-18736
18. Woo H.J., Shaw L.M., Messier J.M., and Mercurio A.M. The major nonintegrin laminin binding protein of macrophages is identical to carbohydrate binding protein 35 (Mac-2). J. Biol. Chem. 265 (1990) 7097-7099
19. Warfield P.R., Makker P.N., Raz A., and Ochieng J. Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis 17 (1997) 101-112
20. Matarrese P., Fusco O., Tinari N., Natoli C., Liu F.T., Semeraro M.L., Malorni W., and Iacobelli S. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer 85 (2000) 545-554
21. Honjo Y., Nangia-Makker P., Inohara H., and Raz A. Down-regulation of galectin-3 suppresses tumorigenecity of human breast carcinoma cells. Clin. Cancer Res. 7 (2001) 661-668
22. O'Driscoll L., Linehan R., Liang Y.H., Joyce H., Oglesby I., and Clynes M. Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res. 22 (2002) 3117-3125
23. Cvejic D., Savin S., Paunovic I., Tatic S., Havelka M., and Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res. 18 (1998) 2637-2642
24. Bresalier R.S., Yan P.-S., Byrd J.C., Lotan R., and Raz A. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80 (1997) 776-787
25. Gillenwater A., Xu X.C., el-Naggar A.K., Clayman G.L., and Lotan R. Expression of galectins in head and neck squamous cell carcinoma. Head Neck 18 (1996) 422-432
26. Schaffert C., Pour P.M., and Chaney W.G. Localization of galectin-3 in normal and diseased pancreatic tissue. Int. J. Pancreatol. 23 (1998) 1-9
27. Cindolo L., Benvenuto G., Salvatore P., Pero R., Salvatore G., Mirone V., Prezioso D., Altieri V., Bruni C.B., and Chiariotti L. Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas. Int. J. Cancer 84 (1999) 39-43
28. Baldus S.E., Zirbes T.K., Weingarten M., Fromm S., Glossmann J., Hanisch F.G., Monig S.P., Schroder W., Flucke U., Thiele J., Holscher A.H., and Dienes H.P. Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation. Tumour Biol. 21 (2000) 258-266
29. Young A.N., Amin M.B., Moreno C.S., Lim S.D., Cohen C., Petros J.A., Marshall F.F., and Neish A.S. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am. J. Pathol. 158 (2001) 1639-1651
30. Vereecken P., Zouaoui-Boudjeltia K., Debray C., Awada A., Legssyer I., Sales F., Petein M., Vanhaeverbeek M., Ghanem G., and Heenen M. High serum galectin-3 in advanced melanoma: preliminary results. Clin. Exp. Dermatol. 31 (2006) 105-109
31. Brustmann H. Galectin-3 and CD1a-positive dendritic cells are involved in the development of an invasive phenotype in vulvar squamous lesions. Int. J. Gynecol. Pathol. 25 (2006) 30-37
32. Song Y.K., Billiar T.R., and Lee Y.J. Role of galectin-3 in breast cancer metastasis. Involvement of nitric oxide. Am. J. Pathol. 160 (2002) 1069-1075
33. Yamazaki D., Kurisu S., and Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci. 96 (2005) 379-386
34. Yamaguchi H., Lorenz M., Kempiak S., Sarmiento C., Coniglio S., Symons M., Segall J., Eddy R., Miki H., Takenawa T., and Condeelis J. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 168 (2005) 441-452
35. Chen W.T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool. 251 (1989) 167-185
36. Condeelis J. How is actin polymerization nucleated in vivo?. Trends Cell Biol. 11 (2001) 288-293
37. Carlier M.F., Ressad F., and Pantaloni D. Control of actin dynamics in cell motility. Role of ADF/cofilin. J. Biol. Chem. 274 (1999) 33827-33830
38. Loisel T.P., Boujemaa R., Pantaloni D., and Carlier M.F. Reconstitution of actin-based motility of Listeria and Shigella using pure proteins. Nature 401 (1999) 613-616
39. Chan A.Y., Bailly M., Zebda N., Segall J.E., and Condeelis J.S. Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion. J. Cell Biol. 148 (2000) 531-542
40. Dawe H.R., Minamide L.S., Bamburg J.R., and Cramer L.P. ADF/cofilin controls cell polarity during fibroblast migration. Curr. Biol. 13 (2003) 252-257
41. Ghosh M., Song X., Mouneimne G., Sidani M., Lawrence D.S., and Condeelis J.S. Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304 (2004) 743-746
42. Atkins D., Lichtenfels R., and Seliger B. Heat shock proteins in renal cell carcinomas. Contrib. Nephrol. 148 (2005) 35-56
43. Thomas X., Campos L., Mounier C., Cornillon J., Flandrin P., Le Q.H., Piselli S., and Guyotat D. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk. Res. 29 (2005) 1049-1058
44. Hwang T.S., Han H.S., Choi H.K., Lee Y.J., Kim Y.J., Han M.Y., and Park Y.M. Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J. Gastroenterol. Hepatol. 18 (2003) 690-700
45. Vargas-Roig L.M., Gago F.E., Tello O., Aznar J.C., and Ciocca D.R. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int. J. Cancer 79 (1998) 468-475
46. Ciocca D.R., Rozados V.R., Cuello-Carrion F.D., Gervasoni S.I., Matar P., and Scharovsky O.G. Hsp25 and Hsp70 in rodent tumors treated with doxorubicin and lovastatin. Cell Stress Chaperones 8 (2003) 26-36
47. Hastie C., Saxton M., Akpan A., Cramer R., Masters J.R., and Naaby-Hansen S. Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cells. Oncogene 24 (2005) 5905-5913
48. Mai J., Waisman D.M., and Sloane B.F. Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim. Biophys. Acta 1477 (2000) 215-230
49. Hajjar K.A., and Acharya S.S. Annexin II and regulation of cell surface fibrinolysis. Ann. N. Y. Acad. Sci. 902 (2000) 265-271
50. Siever D.A., and Erickson H.P. Extracellular annexin. Int. J. Biochem. Cell Biol. 29 (1997) 1219-1223
51. Zhang D., Tai L.K., Wong L.L., Chiu L.-L., Sethi S.K., and Koay E.S.C. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 4 (2005) 1686-1696
52. Takashima M., Kuramitsu Y., Yokoyama Y., Iizuka N., Fujimoto M., Nishisaka T., Okita K., Oka M., and Nakamura K. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5 (2005) 1686-1692
53. Wang Y., and Morrow J.S. Identification and characterization of human SLP-2, a novel homologue of stomatin (Band 7.2b) present in erythrocytes and other tissues. J. Biol. Chem. 275 (2000) 8062-8071
54. Seidel G., and Prohaska R. Molecular cloning of hSLP-1, a novel human brain-specific member of the band 7/MEC-2 family similar to Caenorhabditis elegans UNC-24. Gene 225 (1998) 23-29
55. Sprenger R.R., Speijer D., Back J.W., De Koster C.G., Pannekoek H., and Horrevoets A.J. Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis 25 (2004) 156-172
56. Zhang L., Ding F., Cao W., Liu Z., Liu W., Yu Z., Wu Y., Li W., Li Y., and Liu Z. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma. Clin Cancer Res. 12 (2006) 1639-1646
57. Choi S.L., Choi Y.S., Kim Y.K., Sung N.D., Kho C.W., Park B.C., Kim E.M., Lee J.H., Kim K.M., Kim M.Y., and Myung P.K. Proteomic analysis and the antimetastatic effect of N-(4-methyl)phenyl-O-(4-methoxy) phenyl-thionocarbamate-induced apoptosis in human melanoma SK-MEL-28 cells. Arch. Pharm. Res. 29 (2006) 224-234
58. Chi S.L., and Pizzo S.V. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res. 66 (2006) 875-882